αIIb-Integrin (CD41) associated with blood eosinophils is a potential biomarker for disease activity in eosinophilic esophagitis

Mats W. Johansson, Elizabeth M. McKernan, Paul S. Fichtinger, Evelyn L. Angulo, Jennifer L. Bagley, Kristine E. Lee, Michael D. Evans, Luis D. Lomeli, Deane F. Mosher, Shelly M. Cook, Eric A. Gaumnitz, Sameer K. Mathur

Research output: Contribution to journalArticlepeer-review

2 Scopus citations
Original languageEnglish (US)
Pages (from-to)1699-1701
Number of pages3
JournalJournal of Allergy and Clinical Immunology
Volume145
Issue number6
DOIs
StateAccepted/In press - Jan 1 2020
Externally publishedYes

Bibliographical note

Funding Information:
This study was funded by the National Institutes of Health (grants R21 AI122103 [to S.K.M., E.A.G., and M.W.J.] and T32 AI007635 [to E.L.A.]); Program Project (grant P01 HL088594 [to N.J. Jarjour, D.F.M., and S.K.M.]); Clinical and Translational Science Award (grant U11 RR025011 [to M. K. Drezner]), and University of Wisconsin Carbone Cancer Center (support grant P30 CA014520 [to H. H. Bailey]). The funding source had no involvement in the study design; the data collection, analysis, or interpretation; the writing of the report; or the decision to submit the article for publication.

PubMed: MeSH publication types

  • Journal Article

Cite this